Skip to main content

Market Overview

Thinking About Buying Stock In Starbucks, Peloton Or ChemoCentryx?

Share:
Thinking About Buying Stock In Starbucks, Peloton Or ChemoCentryx?

One of the most common questions traders have about stocks is “Why Is It Moving?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why a stock is moving.

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Deutsche Bank analyst Brian Mullan upgrades Starbucks Corporation (NASDAQ: SBUX) from Hold to Buy and announces $127 price target.

Starbucks is trading 1.9% higher at $113.28.

Keybanc analyst Edward Yruma maintained Peloton Interactive Inc (NASDAQ: PTON) with an Overweight and lowered the price target from $185 to $155.

Peloton is trading 0.8% higher at $86.78.

Raymond James analyst Steven Seedhouse upgraded ChemoCentryx Inc (NASDAQ: CCXI) from Outperform to Strong Buy and raised the price target from $62 to $107.

SVB Leerink analyst Joseph Schwartz upgraded ChemoCentryx from Market Perform to Outperform and raised the price target from $17 to $64.

JP Morgan analyst Anupam Rama upgraded ChemoCentryx from Underweight to Neutral and raised the price target from $14 to $38.

ChemoCentryx is trading 4.9% higher at $40.30.

 

Related Articles (CCXI + PTON)

View Comments and Join the Discussion!

Posted-In: News Analyst Ratings

Latest Ratings

StockFirmActionPT
RGFJefferiesInitiates Coverage On16.0
DHXLake StreetInitiates Coverage On10.0
ENSCLake StreetInitiates Coverage On4.0
TROXUBSUpgrades32.0
VALEB of A SecuritiesMaintains17.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com